NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 92 filers reported holding NUVALENT INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,546,192 | -2.3% | 1,556,367 | -10.4% | 0.01% | 0.0% |
| Q2 2023 | $73,227,656 | +48.8% | 1,736,487 | -8.0% | 0.01% | +40.0% |
| Q1 2023 | $49,223,377 | +15.1% | 1,886,676 | +31.3% | 0.01% | +11.1% |
| Q4 2022 | $42,775,665 | +131.6% | 1,436,389 | +51.2% | 0.01% | +125.0% |
| Q3 2022 | $18,468,000 | +35.4% | 949,967 | -5.5% | 0.00% | +33.3% |
| Q2 2022 | $13,637,000 | -2.4% | 1,005,706 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $13,969,000 | -27.2% | 1,005,706 | -0.8% | 0.00% | -33.3% |
| Q4 2021 | $19,189,000 | -16.7% | 1,013,473 | -3.4% | 0.00% | -25.0% |
| Q3 2021 | $23,024,000 | – | 1,049,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |